These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1243656)

  • 1. [MASCA-model of biochemical-pharmacological drug research. Part 6: Structure-activity relationship and bio-oscillations (author's transl)].
    Mager PP
    Arzneimittelforschung; 1975; 25(12):1864-5. PubMed ID: 1243656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [MASCA-model of the biochemical-pharmacological drug research / part 5: Structure-activity relationships and MACOVA (author's transl)].
    Mager PP
    Arzneimittelforschung; 1975 Nov; 25(11):1745. PubMed ID: 1243081
    [No Abstract]   [Full Text] [Related]  

  • 3. [MASCA-model of the biochemical-pharmacological drug research/ part 4: Structure-activity relationships and MANOVA (author's transl)].
    Mager PP
    Arzneimittelforschung; 1975 Oct; 25(10):1475-6. PubMed ID: 1243023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [MASCA-model of the biochemical-pharmacological drug research. Part 3: Structure-activity relationships and KANORA (author's transl)].
    Mager PP
    Arzneimittelforschung; 1975 Sep; 25(9):1355-6. PubMed ID: 1242657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MASCA-model of biochemical-pharmacological drug research/Part VIII: Examples (author's transl)].
    Mager PP
    Arzneimittelforschung; 1976 Feb; 26(2):185-7. PubMed ID: 7279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [MASCA-Model of biochemical-pharmacological drug research/part 7: Computing scheme for the MASCA-model (author's transl)].
    Mager PP
    Arzneimittelforschung; 1976; 26(1):26-8. PubMed ID: 947168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MASCA-model of the biochemical-pharmacological drug research. Part 2: Multivariate test criterions and methods (author's transl)].
    Mager PP
    Arzneimittelforschung; 1975 Aug; 25(8):1270-2. PubMed ID: 1242357
    [No Abstract]   [Full Text] [Related]  

  • 8. [MASCA-model of the biochemical-pharmacological drug research/part 1: Principle of the univariate structure-activity relationship and definitions of physico-chemical parameters (author's transl)].
    Mager PP
    Arzneimittelforschung; 1975 Jul; 25(7):1006-8. PubMed ID: 1174406
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current problems in effective-substance research. 9. Parameter-free methods for the structure-activity analysis].
    Gäbler E; Franke R; Oehme P
    Pharmazie; 1976; 31(1):1-14. PubMed ID: 768997
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the question of relationship between chemical structure and dermatotropic effect of some aromatic hydrocarbons induced in a biological model (author's transl)].
    Miglierini K; Sak M; Hegyi E
    Cesk Dermatol; 1976 Oct; 51(5):300-5. PubMed ID: 1000636
    [No Abstract]   [Full Text] [Related]  

  • 11. [Multivariate Free-Wilson analysis (author's transl)].
    Mager PP; Seese A
    Pharmazie; 1981 Jun; 36(6):427-9. PubMed ID: 7279991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological activities of a homologous series of pyrazole derivatives including quantitative structure-activity relationships (QSAR).
    Paintz M; Bekemeier H; Metzner J; Wenzel U
    Agents Actions Suppl; 1982; 10():47-58. PubMed ID: 6126091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theoretical approaches to drug design and biological activity: II. Multivariate structure-activity relationships in combination with the multivariate bioassay (MASCA model).
    Mager PP
    Med Res Rev; 1983; 3(4):435-98. PubMed ID: 6358723
    [No Abstract]   [Full Text] [Related]  

  • 14. Principles and practice of Hansch analysis: a guide to structure-activity correlation for the medicinal chemist.
    Tute MS
    Adv Drug Res; 1971; 6():1-77. PubMed ID: 4946617
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influency of phosphorylation on pharmacological properties of biological active compounds (author's transl)].
    Chabrier P; Thuong NT; Chassignol M; Foussard-Blanpin O; Bretaudeau J; Warolin C
    Ann Pharm Fr; 1980; 38(1):65-74. PubMed ID: 7396342
    [No Abstract]   [Full Text] [Related]  

  • 16. [Structure and biological properties of lectins (author's transl)].
    Krop-Watorek A
    Postepy Biochem; 1978; 24(2):221-41. PubMed ID: 693438
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the calculation and the evaluation of combinations of active substances (author's transl)].
    Groeger U; Lang S; Michel HJ
    Pharmazie; 1981; 36(2):81-7. PubMed ID: 7232493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular connectivity studies on quantitative structure-activity of drugs. II. Quantitative structure-activity relationships for leucomycins, lincomycins and clindamycins (author's transl)].
    Wang EH; Du FD; Xiang BR
    Yao Xue Xue Bao; 1981 Feb; 16(2):86-91. PubMed ID: 7304188
    [No Abstract]   [Full Text] [Related]  

  • 19. [Molecular connectivity studies on quantitative structure-activity of drugs. I. Quantitative structure-activity relationships for the central nervous system depressant, 2-imidazolidinone derivatives (author's transl)].
    Xiang BR; Wang FH; Du FD
    Yao Xue Xue Bao; 1981 Jan; 16(1):19-23. PubMed ID: 7246150
    [No Abstract]   [Full Text] [Related]  

  • 20. [Certain aspects of formalization of the diagnostic process in a sequential structure of radiological diagnosis model. Part I (author's transl)].
    Smajkiewicz L; Zbyszewska B
    Pol Przegl Radiol Med Nukl; 1980; 44(1):33-5. PubMed ID: 7422561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.